Marksans Pharma to expand generic drug portfolio in US.

Marksans Pharma to expand generic drug portfolio in US. The company highlighted growth plans during an analyst and institutional investor meet. Focus remains on scaling US market presence with ~$50 million in potential revenue from new filings. Regulatory submissions expected to drive future earnings.

📊 STOCKS: $MARKSANSPHARMA | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Pharma